Teva Pharmaceutical Industries Ltd. ADR

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

92.88%

Market Cap

32.03 Bil.

P/E Ratio

25.54

Dividend Yield

0.00 %

Earnings per Share

1.08 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE27.5 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 09:55:56 PM
DAILY VOLUME (UNITS)66
DAILY HIGH / LOW27.726.6
PREV. DAY'S PRICE27.1 (07/20)
CHANGE DAY BEFORE
+0.40
1.48 %
52 WEEK HIGH / LOW31.3 (07/06)13.25 (08/01)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-0.46-1.351.081.772.71
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
--25.5415.7810.33
PRICE - BOOK RATIO
1.564.654.54--
PRICE - SALES RATIO
0.741.502.08--
PRICE - CASH FLOW RATIO
4.129.7812.58--
Further Key Figures

Master Data

WKN
883035
ISIN
US8816242098
SYMBOL
TEV
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Teva Pharmaceutical ADR
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
1.16 Bil.
MARKET CAPITALISATION
32.03 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-4.58 %
-3.21 %
0.00 %
1.12 %
92.88 %
252.86 %
265.72 %
1.88 %
HIGH28.4031.3031.3031.3031.3031.3031.3031.30
LOW27.1027.1025.6024.4013.257.386.5624.40

Dividende

pro Aktie
Teva Pharmaceutical ADR does not deliver dividend information

Company profile

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.